Compound ID | 2748
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive, Gram-negative & Antimycobacterial |
| Mechanism of action: | RNA synthesis inhibitor. Targets DNA-dependent RNA polymerase |
| Target Pathogen: | Active against methicillin-resistant and -susceptible Staphylococcus aureus, and Mycobacterium tuberculosis |
| Propensity to select resistant mutants: | Yes, at 2x10^-8 mutation frequency |
| Description: | Natural product from Streptomyces spectabilis; chemically related to rifamycin (ansamycin-type); derivatives reported; when clinically tested against Mycobacterium tuberculosis, it showed better efficacy when in combination with isoniazid than on its own |
| Year first mentioned: | 1957 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/135538643 |
| Citations: |
|